During the past decade, Hospital de Sagunto conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Sagunto" #1 sponsor was "PETHEMA Foundation" with 6 trials, followed by "Spanish Breast Cancer Research Group" with 5 trials sponsored, "Tigenix S.A.U." with 4 trials sponsored, "Hospital Arnau de Vilanova" with 3 trials sponsored and "Chinook Therapeutics U.S., Inc." with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Sagunto" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Roche Farma, S.A" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Sagunto" are "Crohn's Disease" (4 trials), "Breast Cancer" (3 trials), "IgA Nephropathy" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Hospital de Sagunto" in a lesser frequency.

Most popular intervention types in "Hospital de Sagunto" are "Drug" (35 trials), "Other" (8 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Cyclophosphamide" (3 trials), "Atrasentan" (2 trials), "Cx601" (2 trials) and "Daunorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Sagunto" are 44 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Sagunto". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Hospital de Sagunto, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Sagunto, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".